A Phase 1-2 of ST316 With Selected Advanced Unresectable and Metastatic Solid Tumors
Clinical trial NCT05848739 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05848739
- Sponsor
- Sapience Therapeutics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-05
- Primary completion
- 2026-12-31
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.